Novo Nordisk
Leading insulin and GLP-1 pharmaceutical manufacturer.
Novo Nordisk is a global pharmaceutical company and the world's largest producer of insulin, as well as a leader in GLP-1 receptor agonists (Ozempic, Wegovy). The company supplies to hospitals, pharmacies and healthcare distributors in over 170 countries.
- Type
- brand seeking distribution
- Location
- Bagsværd, Denmark
- Founded
- 1923
- Website
- novonordisk.com
- Categories
- Medical & Healthcare Supplies
- Markets
- Denmark, United States, Germany, China
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)